cryolife8k51909.htm
 
 
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
washington, d.c. 20549

FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  May 19, 2009

_______________________

CRYOLIFE, INC.
(Exact name of registrant as specified in its charter)
_________________________

Florida
1-13165
59-2417093
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)

1655 Roberts Boulevard, N.W., Kennesaw, Georgia  30144
(Address of principal executive office) (zip code)

Registrant's telephone number, including area code: (770) 419-3355

_____________________________________________________________
(Former name or former address, if changed since last report)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 
Section 5 Corporate Governance and Management

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Stockholder Approval of the CryoLife, Inc. 2009 Employee Stock Incentive Plan

On May 19, 2009, the stockholders of CryoLife, Inc. (“CryoLife” or the “Company”) approved the Company’s 2009 Employee Stock Incentive Plan (the “Plan”).  The Board of Directors of the Company (the “Board”), upon recommendation of the Compensation Committee of the Board, had previously adopted the Plan on February 17, 2009, subject to stockholder approval.

The description of the terms and conditions of the Plan is incorporated herein by reference to the description of the Plan contained in CryoLife’s Definitive Proxy Statement filed on April 7, 2009.


 
 
 
 

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
CRYOLIFE, INC.
   
   
      Date:  May 22, 2009
By:            /s/ D. Ashley Lee
 
Name:   D. Ashley Lee
 
Title:     Executive Vice President, Chief
 
             Operating Officer and Chief
 
             Financial Officer